HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
INDV
Indivior Plc
Healthcare Drug Manufacturers - Specialty & Generic ADR · United Kingdom · Reports in usd
Market Cap: $5.00B
Market Cap
$5.00B
Enterprise Val
$5.34B
P/E Ratio
19.94
P/B Ratio
-34.75
Trailing PEG (1Y)
0.23
As Of
Jul 30, 2026

Overview & Key Metrics

Reporting period: Mar 31, 2026 · Q1 2026
Book Value-$144.0M
Gross Margin87.38%
Profit Margin87.38%
Return on Equity-142.21%
Return on Assets19.07%
Current Ratio0.86
Debt/Equity-3.53
LT Debt/Equity-3.47
Revenue Per Share2.53

Income Statement

Mar 31, 2026
Revenue$317.0M
Cost of Revenue$40.0M
Gross Profit$277.0M
R&D$16.0M
SG&A$124.0M
Operating Expenses$140.0M
Operating Income$137.0M
Interest Expense$7.0M
Tax Expense$26.0M
Net Income$89.0M
EPS (Basic)$0.71
EPS (Diluted)$0.69
EBIT$122.0M
EBITDA$126.0M
Consolidated Income$89.0M
Non-Controlling Interests$0.00

Balance Sheet

Mar 31, 2026
Cash & Equivalents$175.0M
Accounts Receivable$273.0M
Inventory$152.0M
Current Assets$667.0M
LT Investments$27.0M
Property, Plant & Equipment$179.0M
Intangibles$2.0M
Non-Current Assets$530.0M
Total Assets$1.20B
Accounts Payable$178.0M
Current Debt$9.0M
Current Liabilities$779.0M
LT Debt$500.0M
Non-Current Liabilities$562.0M
Total Liabilities$1.34B
Total Debt$509.0M
Retained Earnings-$280.0M
Shareholder Equity-$144.0M
Shares Outstanding125,065,242

Cash Flow Statement

Mar 31, 2026
Operating Cash Flow-$9.0M
Investing Cash Flow-$19.0M
Financing Cash Flow$7.0M
CapEx-$20.0M
Free Cash Flow-$29.0M
Depreciation & Amort.$4.0M
Stock-Based Comp$9.0M
Acquisitions / Disposals$0.00
Investment Activity$1.0M
Debt Issued/Repaid$151.0M
Equity Issued/Repaid-$147.0M
Dividends Paid$0.00
Net Change in Cash-$20.0M
Data cached · Meta cache · Daily cache · Statements cache · TTL 24h